IS4282A
Controlled-release dosage forms of azithromycin
Abstract
A controlled-release dosage form of azithromycin having an improved side effect profile; a process for preparing the dosage form; and a method of treating a microbial infection, comprising administering azithromycin in such a controlled-release dosage form to a mammal, including a human patient, in need of such treatment.
Term
Term ended
Projected expiry passed 2 May 2015, 11.4 years ago.
- Priority
- Filed
- Projected expiry
- Today
74 members in 42 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 23909494 | United States of America | A | |
| 23909494 | United States of America | A | |
| US19940239094 | – | – | – |
Members74
| Document | Office | Kind | |
|---|---|---|---|
| AP9500735A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| IL113516A0 | Israel | A0 | |
| IL113516D0 | Israel | D0 | |
| UY23958A1 | Uruguay | A1 | |
| IS4282AThis record | Iceland | A | |
| CA2189658A1 | Canada | A1 | |
| WO9530422A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2113195A | Australia | A | |
| MA23537A1 | Morocco | A1 | |
| TNSN95051A1 | Tunisia | A1 | |
| BR9501929A | Brazil | A | |
| PE4796A1 | Peru | A1 | |
| CO4290346A1 | Colombia | A1 | |
| AP548A | African Regional Intellectual Property Organization (ARIPO) | A | |
| FI964452A | Finland | A | |
| FI964452A0 | Finland | A0 | |
| FI964452A7 | Finland | A7 | |
| FI964452L | Finland | L | |
| NO964678D0 | Norway | D0 | |
| ZA953627B | South Africa | B | |
| NO964678L | Norway | L | |
| HU9603076D0 | Hungary | D0 | |
| EP0758244A1 | European Patent Office (EPO) | A1 | |
| PL317106A1 | Poland | A1 | |
| LV11729A | Latvia | A | |
| CN1149831A | China | A | |
| JPH09505609A | Japan | A | |
| KR970702727A | Republic of Korea | A | |
| AU680356B2 | Australia | B2 | |
| LV11729B | Latvia | B | |
| BG100960A | Bulgaria | A | |
| OA10320A | African Intellectual Property Organization (OAPI) | A | |
| HRP950277A2 | Croatia | A2 | |
| MX9605419A | Mexico | A | |
| SI9520049A | Slovenia | A | |
| CZ324296A3 | Czechia | A3 | |
| HUT77530A | Hungary | A | |
| SK143296A3 | Slovakia | A3 | |
| NZ283160A | New Zealand | A | |
| RU2130311C1 | Russian Federation | C1 | |
| RO114740B1 | Romania | B1 | |
| JP2977907B2 | Japan | B2 | |
| KR100232297B1 | Republic of Korea | B1 | |
| US6068859A | United States of America | A | |
| CA2189658C | Canada | C | |
| PL179910B1 | Poland | B1 | |
| IL131308A0 | Israel | A0 | |
| IL131308D0 | Israel | D0 | |
| TW420616B | Taiwan Province of China | B | |
| IL113516A | Israel | A | |
| BG63152B1 | Bulgaria | B1 | |
| IL131308A | Israel | A | |
| UA41995C2 | Ukraine | C2 | |
| EP0758244B1 | European Patent Office (EPO) | B1 | |
| MY113059A | Malaysia | A | |
| AT209497T | Austria | T | |
| ATE209497T1 | Austria | T1 | |
| DE69524214D1 | Germany | D1 | |
| ES2163504T3 | Spain | T3 | |
| DK0758244T3 | Denmark | T3 | |
| DZ1880A1 | Algeria | A1 | |
| US2002044965A1 | United States of America | A1 | |
| PT758244E | Portugal | E | |
| DE69524214T2 | Germany | T2 | |
| HRP950277B1 | Croatia | B1 | |
| SK282854B6 | Slovakia | B6 | |
| CN1096862C | China | C | |
| NO315453B1 | Norway | B1 | |
| CZ292360B6 | Czechia | B6 | |
| US7108865B2 | United States of America | B2 | |
| EP0758244B2 | European Patent Office (EPO) | B2 | |
| DE69524214T3 | Germany | T3 | |
| ES2163504T5 | Spain | T5 | |
| DK0758244T4 | Denmark | T4 |
Numbers
- Publication, EPODOC
- IS4282
- Application
- 4282
- Application, DOCDB
- 4282
- Application, EPODOC
- IS19950004282
Titles2
- English
- Dosage-controlled dosage form of azithromycin
- Icelandic
- Leysnistýrð skammtaform af Azithromycín
Classification
- CPC, 11
- A61K31/7048
- A61K31/70
- A61K9/0004
- A61K9/2054
- A61K9/5047
- A61K9/5073
- A61P31/00
- A61P31/04
- A61K9/20
- A61K9/28
- A61K9/00
- IPC, 19
- C07H15 252
- A61K
- A61K9 00
- A61K9 14
- A61K9 20
- A61K9 22
- A61K9 28
- A61K9 50
- A61K31 00
- A61K31 70
- A61K31 7016
- A61K31 7028
- A61K31 7034
- A61K31 704
- A61K31 7048
- A61K47 30
- A61P31 00
- A61P31 04
- C07H17 08